Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
The site’s GMP Certification has been successfully renewed
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Prithwish has close to 28 years of experience in a Commercial role
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Puri is an accomplished leader and financial sector veteran with over four decades of experience
Subscribe To Our Newsletter & Stay Updated
